Daniel A Bochar
Research Area Specialist Lead
Lecturer I in Biological Chemistry
[email protected]

Available to mentor
Daniel A Bochar
Lecturer
  • Qualifications
  • Recent Publications
    • Qualifications
    • Postdoctoral Fellow
      The Wistar Institute, Philadelphia, 2003
    • PhD
      Purdue University West Lafayette, West Lafayette, 1998
    • BS
      University of Illinois at Urbana-Champaign, Urbana, 1992
    Recent Publications See All Publications
    • Journal Article
      Selective and Potent PROTAC Degraders of c-Src Kinase.
      Mao W, Vandecan NM, Bingham CR, Tsang PK, Ulintz P, Sexton R, Bochar DA, Merajver SD, Soellner MB. ACS Chem Biol, 2024 Jan 19; 19 (1): 110 - 116. DOI:10.1021/acschembio.3c00548
      PMID: 38113191
    • Preprint
      Selective and potent PROTAC degraders of c-Src kinase
      Mao W, Vandecan N, Bingham C, Tsang PK, Ulintz P, Sexton R, Bochar D, Merajver S, Soellner M. ChemRxiv, DOI:10.26434/chemrxiv-2023-zncbf
    • Journal Article
      TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform.
      Peiffer AL, Garlick JM, Wu Y, Wotring JW, Arora S, Harmata AS, Bochar DA, Stephenson CJ, Soellner MB, Sexton JZ, Brooks CL, Mapp AK. ACS Med Chem Lett, 2023 Jun 8; 14 (6): 860 - 866. DOI:10.1021/acsmedchemlett.3c00035
      PMID: 37284689
    • Journal Article
      Reply to Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase".
      Johnson TK, Bochar DA, Vandecan NM, Furtado J, Agius MP, Phadke S, Soellner MB. Angew Chem Int Ed Engl, 2022 Nov 14; 61 (46): e202209518 DOI:10.1002/anie.202209518
      PMID: 36283971
    • Journal Article
      Reply to Correspondence on “Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase”
      Johnson TK, Bochar DA, Vandecan NM, Furtado J, Agius MP, Phadke S, Soellner MB. Angewandte Chemie, 2022 Nov 14; 134 (46): DOI:10.1002/ange.202209518
    • Journal Article
      Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase.
      Johnson TK, Bochar DA, Vandecan NM, Furtado J, Agius MP, Phadke S, Soellner MB. Angew Chem Int Ed Engl, 2021 Sep 6; 60 (37): 20196 - 20199. DOI:10.1002/anie.202105351
      PMID: 34292655
    • Journal Article
      Synergy and Antagonism between Allosteric and Active‐Site Inhibitors of Abl Tyrosine Kinase
      Johnson TK, Bochar DA, Vandecan NM, Furtado J, Agius MP, Phadke S, Soellner MB. Angewandte Chemie, 2021 Sep 6; 133 (37): 20358 - 20361. DOI:10.1002/ange.202105351
    • Journal Article
      Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions.
      Liu M, Dexheimer T, Sui D, Hovde S, Deng X, Kwok R, Bochar DA, Kuo M-H. Sci Rep, 2020 Oct 6; 10 (1): 16551 DOI:10.1038/s41598-020-73680-2
      PMID: 33024171